Sepsis-associated acute kidney injury

Ha Huy Duong1, Le Viet Thang2, Nguyen Trung Kien3, Nguyen Van Tam2, Vo Van Hien4, Le Dinh Nam1, Tran Quoc Thang1, Phan Ba Danh1, Do Van Binh1, Le Huu Nhuong1,
1 354 Military Hospital
2 103 Military Hospital
3 Military Medical Department
4 Le Huu Trac National Burn Hospital

Main Article Content

Abstract

Sepsis-associated acute kidney injury (SA-AKI) is common among critically ill patients and represents a major contributor to both disease severity and mortality. The pathophysiology is multifactorial, involving systemic and microcirculatory hemodynamic disturbances, mitochondrial dysfunction, and cellular metabolic reprogramming. Recovery following AKI depends on the balance between adaptive repair mechanisms (endothelial repair, tubular epithelial regeneration) and maladaptive repair, which predisposes patients to chronic kidney disease progression.
Current therapeutic strategies focus on early recognition and timely management of sepsis, including appropriate antimicrobial therapy, fluid resuscitation, and vasopressor support when indicated. In addition, organ support plays a pivotal role, particularly renal replacement therapy (RRT) in severe AKI, although the optimal timing and dosing of RRT remain controversial.

Article Details

References

1. Rudd KE, Johnson SC, Agesa KM, Shackelford KA, Tsoi D, Kievlan DR, et al. Global, regional, and national sepsis incidence and mortality, 1990-2017: analysis for the Global Burden of Disease Study. Lancet (London, England). 2020;395(10219):200-11.
2. Takeuchi T, Flannery AH, Liu LJ, Ghazi L, Cama-Olivares A, Fushimi K, et al. Epidemiology of sepsis-associated acute kidney injury in the ICU with contemporary consensus definitions. Critical care (London, England). 2025;29(1):128.
3. Tran DQ, Vu D, Nguyen HTN, al. e. Value of serum thrombomodulin and angiopoietin-2 in detection of AKI in sepsis: a prospective study from Vietnam. Int J Gen Med. 2023;16::3297-310.
4. Nian W, Tao W, Zhang H. Review of research progress in sepsis-associated acute kidney injury. Front Mol Biosci. 2025;12:1603392.
5. Xu N, L. Z. Sepsis-associated Acute Kidney Injury: Epidemiology, Pathophysiology, and Management Strategies in Critical Care. Nature Cell and Science. 2025;3(1):54-61.
6. Poston JT, Koyner JL. Sepsis associated acute kidney injury. BMJ (Clinical research ed). 2019;364:k4891.
7. Petejova N, Martinek A. Acute kidney injury following acute pancreatitis: A review. Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia. 2013;157(2):105-13.
8. Evans L, Rhodes A, Alhazzani W, Antonelli M, Coopersmith CM, French C, et al. Executive Summary: Surviving Sepsis Campaign: International Guidelines for the Management of Sepsis and Septic Shock 2021. Crit Care Med. 2021;49(11):1974-82.
9. Meyhoff T.S. , Hjortrup P.B. , Wetterslev J. . Restriction of Intravenous Fluid in ICU Patients with Septic Shock. The New England journal of medicine. 2022;386:2459-70.
10. Xiao C, Xiao J, Cheng Y, al. e. The Efficacy and Safety of Early Renal Replacement Therapy in Critically Ill Patients With Acute Kidney Injury: A Meta-Analysis With Trial Sequential Analysis of Randomized Controlled Trials. Frontiers in medicine. 2022;9.